tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

EKF Diagnostics Buys Back Shares and Adjusts Major Shareholder’s Stake

Story Highlights
  • EKF Diagnostics repurchased 71,000 shares into treasury, leaving 434.7 million voting shares outstanding.
  • The buyback included 21,000 shares from Harwood-managed funds to keep director Christopher Mills’ indirect stake near 30%.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
EKF Diagnostics Buys Back Shares and Adjusts Major Shareholder’s Stake

Claim 70% Off TipRanks This Holiday Season

EKF Diagnostics Holdings ( (GB:EKF) ) has shared an update.

EKF Diagnostics Holdings has repurchased 71,000 of its own ordinary shares at a weighted average price of 25.3 pence, with the shares to be held in treasury, leaving 434,722,112 shares in issue carrying voting rights. As part of the buyback, 21,000 shares were acquired from funds managed by Harwood to ensure that non-executive director Christopher Mills’ aggregate indirect holding, now 128,193,000 shares, remains at around 30% of the company’s voting rights, a move that stabilises the shareholder structure and supports compliance with UK disclosure and takeover thresholds.

The most recent analyst rating on (GB:EKF) stock is a Hold with a £27.00 price target. To see the full list of analyst forecasts on EKF Diagnostics Holdings stock, see the GB:EKF Stock Forecast page.

Spark’s Take on GB:EKF Stock

According to Spark, TipRanks’ AI Analyst, GB:EKF is a Neutral.

EKF Diagnostics Holdings receives a score of 67, driven by strong financial performance and a positive earnings call. The company’s robust balance sheet and improved profitability are significant strengths. However, technical indicators suggest potential bearish momentum, and the valuation is moderate. The positive outlook from the earnings call, including strategic growth plans and a share buyback program, enhances the overall score.

To see Spark’s full report on GB:EKF stock, click here.

More about EKF Diagnostics Holdings

EKF Diagnostics Holdings is an AIM-listed global diagnostics business headquartered in Penarth near Cardiff, specialising in point-of-care analysers in hematology and diabetes, as well as life sciences services focused on specialist enzyme manufacturing and custom products for diagnostic, food and industrial applications. The company operates five manufacturing sites across the US and Germany and sells into more than 120 countries worldwide.

Average Trading Volume: 523,880

Technical Sentiment Signal: Strong Sell

Current Market Cap: £110.1M

Find detailed analytics on EKF stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1